The global Gynecological Cancers Therapeutics market size was valued at US$ 12.34 billion in 2024 and is projected to reach US$ 18.56 billion by 2030, at a CAGR of 7.0% during the forecast period 2024-2030.
The United States Gynecological Cancers Therapeutics market size was valued at US$ 4.56 billion in 2024 and is projected to reach US$ 6.78 billion by 2030, at a CAGR of 6.8% during the forecast period 2024-2030.
Therapeutic treatments targeting various gynecological cancers.
Clinical trials reached 425 in 2023. Targeted therapies grow at 8.5% annually. Market saw 45% increase in immunotherapy adoption. Approvals obtained in 52 countries. Future investments of US$ 5.23 billion planned by 2026. North America leads with 42% market share.
Report Overview
Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer.
Get free sample of this report at :
https://www.24marketresearch.com/download-free-sample/8017961/global-gynecological-cancers-therapeutics-2024-943
Locked
